Jangsoon Lee

8PUBLICATIONS
36CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 15, 2026
ATR inhibition potentiates the antitumor efficacy of HER3-DXd in HER3-positive/HR-positive breast cancer by increasing DNA damage.

|Jan 27, 2026
Payload Diversification Overcomes Resistance and Guides Sequential Antibody-Drug Conjugate Therapy in Breast Cancer.

Dileep Reddy Rampa, Minji Seo, Nanae Ogata

|Nov 27, 2025
Antibodies blocking PlGF or VEGF interactions with the NRP1 receptor mediate anti-proliferative effects.

Samuel A Blackman, Ahlam N Qerqez, Alison G Lee

|Sep 27, 2025
Dual Therapeutic Impact of AXL Inhibitor AB-329: Chemotherapy Sensitization and Immune Microenvironment Reprogramming in TNBC.

Dileep Reddy Rampa, Jon A Fuson, Huey Liu

|Jun 13, 2025
Bioactive Compounds from Dodonaea viscosa Flowers: Potent Antibacterial and Antiproliferative Effects in Breast Cancer Cells.

Achara Raksat, Daniel Yee, Young Jin Gi

|Nov 26, 2024
Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor-Positive Triple-Negative Breast Cancer by Inhibiting c-MYC-mediated Tumorigenesis.

Xuemei Xie, Maroua Manai, Dileep R Rampa

Pageof 2

Frequent Collaborators

5 joint publications

Naoto T Ueno

3 joint publications

Dileep Reddy Rampa

2 joint publications

Jennifer A Maynard

2 joint publications

Debu Tripathy